References

ACOG 2020 Cervical Cancer Screening recommendations. https://www.acog.org/Patients/FAQs/Cervical-Cancer-Screening.

ACOG HPV Vaccination Information. https://www.acog.org/store/products/patient-education/pamphlets/womens-health/human-papillomavirus-vaccination

American Cancer Society. (n.d.). HPV vaccines: Updated.https://www.cancer.org/cancer/cancer-causes/infectious-agents/hpv/hpv-vaccines.html

ATHENA HPV clinical trial. (n.d.). https://pubmed.ncbi.nlm.nih.gov/21944226/.

Basic information about cervical cancer. (n.d.). https://www.cdc.gov/cervical-cancer/about/?CDC_AAref_Val=https://www.cdc.gov/cancer/cervical/basic_info/.

Cancer statistics: Cases. (n.d.). https://www.cdc.gov/cancer/hpv/cases.html?CDC_AAref_Val=https://www.cdc.gov/cancer/hpv/statistics/cases.htm.

CDC Guidelines Summary. (n.d.). https://www.cdc.gov/cervical-cancer/screening/?CDC_AAref_Val=https://www.cdc.gov/cancer/cervical/basic_info/screening.htm.

Cervical cancer. American Cancer Society. (n.d.). https://www.cancer.org/cancer/types/cervical-cancer.html.

Cervical cancer. National Cancer Institute. (n.d.). http://www.cancer.gov/cancertopics/types/cervical.

Cervical cancer. World Health Organization. (n.d.). https://www.who.int/news-room/fact-sheets/detail/cervical-cancer.

Cervical cancer screening. NCCC. (n.d.). https://www.nccc-online.org/hpvcervical-cancer/cervical-cancer-screening/#.

Cervista™ HPV 16/18 FDA Approval Letter. (n.d.). http://www.accessdata.fda.gov/cdrh_docs/pdf8/P080015a.pdf.

Cervista™ HPV HR package insert. Hologic. (nd.). https://www.hologic.com/sites/default/files/package-insert/15-3053-001_106_01.pdf.

Cervista™ HPV HR and Genfind™ DNA extraction kit, FDA approval letter. (n.d.). https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P080014.

Check, W. (2014). Data spark new directions in cervical cancer. CAP TODAY. http://captodayonline.com/data-spark-new-directions-in-cervical-cancer/.

Check, W. (2014). Study: primary HPV test 'merits consideration.' CAP TODAY. http://captodayonline.com/study-primary-hpv-test-merits-consideration/.

Chin-Hong, P., & Klausner, J. (2004). Diagnostic tests for HPV infection. Medical Laboratory Observer.10-16.

Cobas 4800 HPV test pack insert. (n.d.). http://www.scribd.com/doc/84100610/cobas4800HPVtestPackInsert.

Cobas HPV test, Roche molecular systems FDA application. (n.d.). http://www.accessdata.fda.gov/cdrh_docs/pdf10/P100020c.pdf.

Cobo, F., Concha, A., & Ortiz, M. (2009). Human papillomavirus (HPV) type distribution in females with abnormal cervical cytology: A correlation with histological study. Virology Journal. 3:60-66.

Cox, J., Moriarty, A., Castle, P. (2009). Commentary on statement on HPV DNA test utilization. American Journal Clinical Pathology. 131:770-773.

DeMay, R. (2007). Practical principles of cytopathology. American Society for Clinical Pathology Press.

Digene hybrid capture 2 high-risk HPV DNA test, FDA approval letter. (n.d.). https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P890064S009.

Gardasil 9 FDA approval. (n.d.). https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm622715.htm.

Gardasil 9 product information-FDA. (n.d.). https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm426445.htm.

Hariri, S., Unger, E., Sternberg, M., et al. (2011). Prevalence of genital human papillomavirus among females in the United States, the National Health and Nutrition Examination Survey, 2003–2006. Journal of Infectious Diseases. 204(4):566–573.

HPV and cancer. (n.d.). National Cancer Institute Fact Sheet. http://www.cancer.gov/cancertopics/factsheet/risk/hpv.

HPV and cancer statistics. (n.d.). CDC. https://www.cdc.gov/united-states-cancer-statistics/publications/hpv-associated-cancers.html.

HPV vaccine fact sheet. (n.d.). National Cancer Institute. https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-vaccine-fact-sheet.

HPV vaccine recommendations. (2024, July 9). Human Papillomavirus (HPV). https://www.cdc.gov/hpv/hcp/vaccination-considerations/index.html

Human papillomavirus DNA detection with genotyping, high-risk types by PCR, ThinPrep. Mayo Clinic website. Available at: http://www.mayomedicallaboratories.com/test-catalog/Clinical+and+Interpretive/62598.

HPV Tests: Cervical Cancer: Detection Diagnosis and Staging: American Cancer Society: Available at https://www.cancer.org/cancer/cervical-cancer/detection-diagnosis-staging/screening-tests/hpv-test.html.

HPV Vaccination: Committee Opinion, Clinical Guidance: ACOG, available at https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2020/08/human-papillomavirus-vaccination

Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices, Weekly / August 16, 2019 / 68(32);698–702. Available at https://www.cdc.gov/mmwr/volumes/68/wr/mm6832a3.htm

HPV Vaccine Fact Sheet: Recommendations: National Cancer Institute (NCI), Available at https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-vaccine-fact-sheet

Human Papillomavirus (HPV) Vaccines. National Cancer Institute. Available at http://www.cancer.gov/cancertopics/factsheet/prevention/HPV-vaccine.

Key Statistics for Cervical Cancer: American Cancer Society: Available at https://www.cancer.org/cancer/cervical-cancer/about/key-statistics.html and https://cancerstatisticscenter.cancer.org/?_ga=2.262167304.547065751.1597685749-1295356790.1550159979#!/cancer-site/Cervix

Katki HA, Kinney WK, Fetterman B, et al. Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice. Lancet Oncology. 2011;12(7):663-672.

Markowitz LE, Sternberg M, Dunne EF, et al. Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: national health and nutrition examination survey 2003-2004. Infectious Disease. 2009;200:1059-1067.

Molecular Diagnostics Fundamentals, Methods, and Clinical Applications. Leal Buckingham and Maribeth L. Flaws. Philadelphia: FA Davis Company; 2007.

Moyer VA, on behalf of the U.S. Preventive Services Task Force. Screening for Cervical Cancer: U.S. Preventive Services Task Force Recommendation Statement. Annals of Internal Medicine. 2012; 156(12):880-91.

National Cervical Cancer Coalition, NCCC, Cervical Cancer Overview, available at https://www.nccc-online.org/hpvcervical-cancer/cervical-cancer-overview/

Onclarity™ HPV Assay. BD. (nd.). https://www.accessdata.fda.gov/cdrh_docs/pdf16/P160037S017C.pdf

Open Reading Frames (ORF), SCFBIO, Tutorial, Available at http://www.scfbio-iitd.res.in/tutorial/orf.html

Open Reading Frames: National Center for Biotechnology Information, U.S. National Library of Medicine, Available at https://www.ncbi.nlm.nih.gov/mesh?Db=mesh&Cmd=DetailsSearch&Term=%22Open+Reading+Frames%22%5BMeSH+Terms%5D

Rao A, Young S, Erlich H, et al. Development and characterization of the Cobas HPV test. J Clin Microbiol. May 2013;51(5):1478-1484.

Roche receives FDA approval for Cobas HPV test for use on the Cobas 6800/8800 Systems to identify women at risk for cervical cancer: Available at https://www.roche.com/media/releases/med-cor-2020-04-21.htm

Saslow D, Solomon D, Lawson HW, et al.: American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer. J Low Genit Tract Dis 2012;16(3):175-204.

Schutzbank TE, Jarvis C, Kahmann N, et al. Detection of high-risk papillomavirus DNA with commercial invader-technology-based analyte-specific reagents following automated extraction of DNA from cervical brushings in Thinprep media. Journal of Clinical Microbiology. 2007;45:4067-4069.

Stoler MH, Wright TC, Sharma A, et al. High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study. Am J Clin Pathol. 2011;135(3):468-475.

The American Congress of Obstetricians and Gynecologists. ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists: Screening for Cervical Cancer. November 2012.

Updated ASCCP management guidelines. Available at: https://www.asccp.org/clinical-practice/management-guidelines.

U.S Preventive Services Task Force: Screening for Cervical Cancer: Recommendation Statement, Am Fam Physician. 2019 Feb 15;99(4): https://www.aafp.org/afp/2019/0215/od1.html.

US Preventive Services Task Force, August 21, 2018, JAMA. 2018;320(7), available at https://jamanetwork.com/journals/jama/fullarticle/2697704.

US Cancer Statistics, CDC, available at https://gis.cdc.gov/Cancer/USCS/DataViz.html

USPSTF cervical cancer screening recommendation: Task Force Recommendation, August 21, 2018, JAMA, 2018: 320(7), available at https://jamanetwork.com/journals/jama/fullarticle/2697704.

USPSTF HPV Testing, Aug 2018, guidelines on HPV testing, available at: https://www.onclive.com/web-exclusives/uspstf-hpv-testing-alone-adequate-cervical-cancer-screening-for-some-women.

USPSTF Final Recommendation Statement: Cervical Cancer: Screening, Aug 2018, available at:https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/cervical-cancer-screening2#consider.

Vernick JP, Steigman, CK. The HPV DNA virus hybrid capture assay: what is it—and where do we go from here? Medical Laboratory Observer. Mar 2003:8-13.

Voss JS, Kipp BR, Campion MB, et al. Comparison of fluorescence in situ hybridization, hybrid capture two and polymerase chain reaction for the detection of high-risk human papillomavirus in cervical cytology specimens. Analytical and Quantitative Cytology and Histology. 2009;31:208-216.

What are the FDA-approved indications for the human papillomavirus (HPV) DNA test? Updated: Feb 20, 2020 :Author: Peter A Gearhart, MD, Available at https://www.medscape.com/answers/219110-56119/what-are-the-fda-approved-indications-for-the-human-papillomavirus-hpv-dna-test

What should I know about screening: Gynecologic cancers. CDC website. Available at: https://www.cdc.gov/cervical-cancer/screening/?CDC_AAref_Val=https://www.cdc.gov/cancer/cervical/basic_info/screening.htm.

World Health Organization: WHO. (2024, March 5). Cervical cancer. https://www.who.int/news-room/fact-sheets/detail/cervical-cancer

Wright TC, Stoler MH, Behrens CM, et al. The ATHENA human papillomavirus study: design, methods, and baseline results. Am J Obstet Gynecol. 2012Jan;206(1):46.e1-46.e11.

Wright TC Jr, Stoler MH, Sharma A, et al.: Evaluation of HPV-16 and HPV-18 genotyping for the triage of women with high-risk HPV positive, cytology-negative results. Am J Clin Pathol. 2011 Oct;136(4):578-586.

Yousefi, Z., Aria, H., et al. "An Update on Human Papilloma Virus Vaccines: History, Types, Protection, and Efficacy." Front. Immunol, Vol 12, 26 Jan 2022. https://doi.org/10.3389/fimmu.2021.805695.